Fusion Antibodies plc (FAB.L) (LON:FAB)’s share price gapped down prior to trading on Thursday . The stock had previously closed at $126.50, but opened at $118.50. Fusion Antibodies plc (FAB.L) shares last traded at $124.00, with a volume of 2,381 shares traded.
The company has a market capitalization of £31.54 million and a P/E ratio of -41.33. The firm has a fifty day simple moving average of GBX 117.92 and a 200-day simple moving average of GBX 117.20. The company has a quick ratio of 5.84, a current ratio of 6.32 and a debt-to-equity ratio of 4.19.
Fusion Antibodies plc (FAB.L) Company Profile (LON:FAB)
Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. The company offers monoclonal antibody discovery and development services; and a range of antibody engineering services for various stages of therapeutic and diagnostic antibody development.
Featured Article: What is the CAC 40 Index?
Receive News & Ratings for Fusion Antibodies plc (FAB.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fusion Antibodies plc (FAB.L) and related companies with MarketBeat.com's FREE daily email newsletter.